August 20, 2019 Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollarsRead more
August 15, 2019 Bayer provides produce growers with holistic approach to field challenges during first ever Agriculture and Innovation ShowcaseRead more
August 8, 2019 Bayer acquires BlueRock Therapeutics to build leading position in cell therapyRead more
August 6, 2019 Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real AssetsRead more
SPECIALIZED PRESS July 31, 2019 Not intended for U.S. and UK MediaU.S. FDA approves darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancerRead more
SPECIALIZED PRESS July 26, 2019 Not intended for U.S. and UK MediaBayer receives positive CHMP opinion for precision oncology treatment larotrectinib with first ever tumor-agnostic indication in in EuropeRead more
July 24, 2019 Bayer and White Ribbon Alliance announce three-year renewal of partnership to improve the every day health of women, infants and children through self-careRead more
SPECIALIZED PRESS July 18, 2019 Not intended for U.S. and UK MediaBayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with colorectal cancerRead more
